Archive for the ‘MOMENTUM’ Category

IHIF Signs Partnership Agreement With Scottish Lifesciences Association

May 17, 2017

 Builds New Market Opportunities for State Industry Members

Contact: Kristin Jones, IHIF, kjones@ihif.org +1-317-752-9809

(Indianapolis,IN USA and Edinburgh, Scotland UK- May 16, 2017) — The Indiana Health Industry Forum (IHIF) and the Scottish Lifesciences Association (SLA) have signed a Memorandum of Understanding to share member benefits between the two organizations.  IHIF and SLA share the same essential vision with regards to creation and maintenance of an environment that nurtures and supports life sciences companies.  The objectives are to foster innovation and valuable, dynamic links between US-based member companies of IHIF and Scotland-based member companies of SLA.

 

According to Scott Johnstone, CEO of the SLA, “IHIF and SLA intend to represent the USA and EU to each other as practical for the mutual benefit of our organizations and our member companies.  Through this relationship, we intend to increase the visibility, sales, investment, regulation, and innovation prospects for our member companies”.

 

Both organizations are members of the multi-state Turnpike Partnership, an innovation-driven network of resources and organizations built to support and enhance the life sciences industry. Scotland is a key international partner with a life sciences cluster of similar size and scope to Indiana’s.

 

Building on an already strong trade relationship, “IHIF and SLA were able to come together through the Turnpike Partnership and build an alliance that will directly benefit our members”, said Kristin Jones, President and CEO of IHIF.  “The partnership with SLA is a further expansion of our international network and will give our members strategic access to UK and European markets at a time of dynamic change.  We also look forward to working with members of SLA as they build their business networks and explore opportunities in the U.S.”

 

The MOU was signed at the 2017 Derby Summit, an annual event for the Kentucky Life Sciences Council.  The Scottish delegation also visited Boston and IHIF representatives attended the May 11 Spring Members Meeting for the SLA in Glasgow, Scotland.

 

About SLA

With 135 member companies and organisations, the SLA is the voice of Scotland’s vibrant life sciences industries to investors, NHSScotland, the Scottish and UK Governments, and the wider community.  The SLA is driven by and network with its members through 14 Special Interest Groups and 4 sub-groups.  The SLA helps to grow members’ businesses, and engage with the NHS and Government to grow the life sciences sector in Scotland.

 

For more information: http://www.scottishlifesciencesassociation.org.uk

 

About IHIF

IHIF is a statewide trade association representing Indiana’s health science business community.  The diverse members of the Indiana Health Industry Forum generate the collective voice of the state’s health and life science industry.  Our mission is to connect key stakeholders to: enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation.

 

For more information: http://www.ihif.org

SLA Mou

Kristin Jones (IHIF) and Scott Johnstone (SLA) sign agreement to trade member services.

###

FAST BioMedical Raises $8 Million as part of Series A2 Financing Round

May 3, 2017

Carmel, Indiana – May 3, 2017 – FAST BioMedical, Inc. today announced it has secured $8 million of additional financing.  $5 million comes from a Series A2 Financing led by one new investor, F&M Investment Office.  This financing augments $3 million of grant funding received as a competing renewal award from the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health.  The proceeds will primarily be used to advance clinical trials of the company’s technology as well as to hire additional talent and advance the company’s global patent portfolio.

“This financing is an important and validating step to continue our progress,” said Joe Muldoon, FAST BioMedical Chief Executive Officer.  “We have already begun adding talent to the team, and are excited about their ability to immediately add value”

“FAST BioMedical has enormous potential to serve large unmet medical needs with its innovative technology,” said Mr. McClure, President of F&M Investment Office.  “We are delighted to partner with them, and see great promise in the ability to favorably impact critical patient care. ”

About FAST BioMedical

FAST BioMedical is a private, clinical-stage medical technology company in Carmel, Indiana.  The company’s globally patented first-in-class technologies directly measure blood volume and kidney function in a clinically viable way.  This has the potential for profound impact on care of congestive heart failure, major surgery, sepsis, critical care, and kidney disease patients.   The company has been financially supported by the NIH, Elevate Ventures, the Indiana 21st Century Fund, Rose-Hulman Ventures, BioCrossroads, Indiana University Medical Group, The Purdue Foundry Fund, Ellipsis Ventures, StepStone Partners, and private family office investors. The FDA has determined the company’s technology met the requirements for an Expedited Review.

These products are investigational and not yet approved for human use.

For more information, please visit www.FASTBioMedical.com

MOMENTUM Final Pitch Presentations 12-9-15

February 19, 2016

The three companies selected to participate in the first cycle of IHIF’s MOMENTUM Team Mentorship Program presented their final pitch presentations on December 9th, 2015.  You may view the video below:

Presenting companies were:

  • Eric Graban, Quarry BioScience (begins at 5:10)
  • Erik Robinson, Sintact Medical Systems (begins at 19:00)
  • Aleks Davis, B2S Laboratories (begins at 33:12)

For more information on MOMENTUM, becoming a sponsor, mentor, or mentee company, please visit http://www.ihif.org/pages/mentorship

Thank you to our Cycle 1 Sponsors:

Indiana CTSI – https://www.indianactsi.org/

Barnes & Thornburg LLPhttp://www.btlaw.com

The Office of Small Business and Entrepreneurship (OSBE) – http://www.in.gov/osbe/

Ivy Tech/Gayle & Bill Cook Center for Entrepreneurship – https://www.ivytech.edu/bloomington/entrepreneurship/

 

IHIF Welcomes Mindray for First Discovery Days Program

January 7, 2016

 

Momentum Logo June 2014

Discovery Days

February 17-18, 2016

Mindray logo

 

The Indiana Health Industry Forum is pleased to announce that we have finalized dates for a company visit to Indiana by Mindray.   IHIF will be hosting company representatives here in Indianapolis on February 17th -18th for our first Discovery Days program!  Mindray representatives are interested in meeting Indiana businesses working in two areas: 1) in-vitro diagnostics and 2) assistive technologies, including health IT applications.  They are interested in meeting with both companies with established products looking to expand their market into China as well as identifying novel technologies that could use a developmental partner.   Mindray offers investment capital, assistance with CFDA approval, and joint venture opportunities.

About Mindray Medical International

Mindray was founded in 1991 in Shenzhen, China, with a mission to deliver high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. Over the last 17 years, we have become a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence. We are expanding our distribution network, sales and sales support staff to bring our products closer to end users. We currently have 29 local sales and service offices in China, as well as sales and service subsidiaries in Amsterdam, Istanbul, London, Mexico City, Moscow, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver.   For more information, please visit http://www.mindraynorthamerica.com/about/

Apply to meet

If you have technologies or know of companies that may be interested in meeting with Mindray’s technology development representatives, please let us know!  IHIF is working to identify a pool of potential companies/technologies and then, working with Mindray, we’ll put together a short list of invitees to a 1-on-1 meeting with them here in Indianapolis.   Please submit a short (1 page) description of the company/technology to get things started.    Please submit descriptions to IHIF at info@ihif.org.   We will begin notifying accepted applicants by January 20th.

Boehringer Ingelheim Day with MassBio

September 23, 2015

Boehringer Ingelheim Day with MassBio

2:00 – 7:30pm

MassBio and Catalyst restaurant at 300 Technology Square, Cambridge, MA 02139

October 8th, 2015

 

The Indiana Health Industry Forum has been invited to submit member profiles for consideration in the Boehringer Ingelheim Pharma Days program.  This event will be held in Boston, October 8th and is organized by MassBio – IHIF’s counterpart organization in Massachusetts.  If you would like to be considered for a one-on-one meeting with Boehringer Ingelheim, please submit a one-pager describing your program of interest to Kristin Jones at IHIF (kjones@ihif.org) by September 30th.  Please do not disclose confidential information. If selected, you must be able to travel to Boston on October 8th to participate in the meetings.

 *****

Please join us on Thursday, October 8th, 2015 for a private meeting and reception with a select group of MassBio members and senior leaders from Boehringer Ingelheim.

Boehringer Ingelheim will provide an overview of its Research & Development organization, Venture fund, therapeutic areas of interest and models for early and late stage licensing partnerships. There will be an opportunity to request one–to-one meetings. A poster competition and pitch contest will take place and a networking reception will follow the program. An innovation prize will be awarded to the winning start-up from the pitch contest at the reception.

One-on-one meetings may be requested by participants.

Boehringer Ingelheim will have teams within the following areas participating in one-on-one meetings: CNS, Oncology, Cardiometabolic, Immunology, Respiratory, Hearing loss, Microbiome, Regenerative medicine and Gene medicine.  For more details, see list below.

Agenda:

2:00 – 3:00pm               Registration and Poster presentation vote for Innovation Prize

Attendees will receive Massbio Dollars to invest into the top 3 most innovative technologies presented.

 

3:00 – 3:05pm               Welcome by MassBio Robert K. Coughlin, President and CEO at MassBio

 

3:05 – 3:30pm            Boehringer Ingelheim Partnering – Working Together for Better Health

  • Paola Casarosa, Corp VP, Business Development & Licensing/ Prescription Medicines

 

3:30 – 4:00pm            Discovery Research and External Innovation

  • Clive Wood, Corp Senior VP, Discovery Research

 

4:00 – 4:30pm            Boehringer Ingelheim Corporate Venture Fund

  • Frank Kalkbrenner, VP, Head of the Boehringer Ingelheim Venture Fund

 

4:30 – 5:00pm               Innovation Prize pitches and judging

 

5:00 – 5:30pm               Boehringer Ingelheim closing remarks and Q&A

 

5:30 –7:00pm                Reception – Catalyst
Innovation Prize winner will be announced at the reception

 

This event, part of the MassBio Pharma Day Series, will provide a great opportunity to network with Boehringer Ingelheim licensing and therapeutic area leaders and learn how a biopharmaceutical company evaluates external research and approaches licensing and partnerships.

 

Current Areas of Interest:

 

    • Central Nervous System
  • Alzheimer’s disease
  • Schizophrenia (focus: negative symptoms and/or cognitive impairment)
  • Depression (focus: treatment-resistant depression)
  • Impulse control disorders

Out of scope: Monoamine uptake inhibitors or monoamine receptor modulators, Compounds with undefined mechanism of action

    • Oncology
  • For clinical stage opportunities: Focus on lung cancer and haematology – irrespective of the MoA
  • Up to IND-ready stage:
  • Cancer cell -directed therapies
    • Growth signaling
    • Apoptosis regulation
    • Epigenetic regulation
    • Protein homeostasis
    • Additional areas of focus will emerge from scientific breakthroughs in cancer biology (e.g. genome integrity, splicing, protein translation, stem cell / developmental pathways, miRNAs)
  • Immune cell -directed therapies
    • Immune cell re-activation
    • Immune cell re-direction
    • Immune cell priming
    • Increased focus in the future will be on lymphocyte trafficking

 

  • Immunology
    • Crohn’s disease and ulcerative colitis
    • Systemic lupus erythematosus (including lupus nephritis)
    • Rheumatologic disorders such as RA (limited to mechanisms that show superior efficacy compared to current standard of care) and spondyloarthritis
    • Systemic sclerosis-scleroderma

Out of Scope: Microbial therapeutics and Gene therapy

 

  • Cardiometabolic
    • Chronic Kidney Diseases and Diabetic Nephropathy
    • Diabetic Retinopathy
    • NASH (Nonalcoholic steatohepatitis) and liver fibrosis
    • Obesity (CV-benefit and patient relevant weight loss >10%)
    • Type 2 Diabetes (evidence for disease modification, CV-risk reduction and/or significant weight reduction)

 

  • Respiratory
    • Chronic Obstructive Pulmonary Disease
    • Asthma
    • Interstitial Pulmonary Fibrosis
    • Cystic Fibrosis
    • Acute Lung Injury or Acute Respiratory Distress Syndrome

 

  • Research Beyond Borders
  • Microbiome:
    • Novel bacteria/bacterial products and their causal role in human health & disease (esp. related to autoimmune, CNS, oncology  and cardiometabolic disorders)
    • Microbiome triggers which impact host immune/inflammatory response & barrier function Depression (focus: treatment-resistant depression)
    • Elucidation of associated pathways & discrete targets (both host & microbiome-derived) for therapeutic intervention
  • Regenerative Medicine:
    • Molecular understanding of mechanisms involved in tissue degeneration
    • New targets or methods for identifying targets that are implicated in the mobilization and/or differentiation of endogenous stem cells/progenitor cells
    • Approaches that may modulate muscle/bone/cartilage degeneration, and/or neurodegeneration
  • Gene Therapy:
    • Rare diseases with high unmet medical need as entry, enabling BI to become a leader in the field; including proprietary assets available for potential partnering
    • Technology platform development, focusing on inducible system for regulatable expression of therapeutic products in the context of AAVs, ensuring applicability of gene therapies in nonlife-threatening diseases
  • Hearing Loss:
    • Understanding of mechanisms involved in hearing loss and approaches with potential to restore hearing or reduce loss
  • Age-related, as well as noise and drug-induced hearing loss

 

 

 

Boehringer Ingelheim Attendees:

 

Dr. Paola Casarosa, Corp. VP, Bus. Dev. & Licensing/Prescription Medicines

Dr. Monica Cheng, Global Licensing, Cardiometabolic Diseases, Bus. Dev. & Licensing/Prescription Medicines

Dr. Laurie Churchill, Global Head Immunology, Bus. Dev. & Licensing/Prescription Medicines

Dr. Henri Doods, VP, Research Beyond Borders

Dr. Jay Fine, Vice President & Global Therapeutic Area Head Immunology and Respiratory Diseases Research

Dr. Christine Grygon, Executive Director, Bus. Dev. & Licensing/Prescription Medicines

Dr. Martin Heidecker, Head of Venture Fund USA

Dr. Jullian Jones, Global Licensing, Oncology

Dr. Frank Kalkbrenner, VP, Venture Fund

Dr. Cyrille Kuhn, Executive Director, Head of Research Beyond Borders

Dr. Michael Mark, Global Head CardioMetabolic Diseases Research

Dr. Klaus Mendla, Global Head CNS, Bus. Dev. & Licensing/Prescription Medicines

Mr. Imran Nasrullah, Innovation Sourcing, Bus. Dev. & Licensing/Prescription Medicines

Dr. Chad Nivens, Global Head Respiratory, Bus. Dev. & Licensing/Prescription Medicines

Mr. Andrew Owenson, Corp. SVP, Therapeutic Area Head Respiratory

Dr. Michel Pairet, Corp. SVP, R&D non-clinical

Dr. Glyn Parkin, Corp. SVP, Therapeutic Area Head Cardiometabolic Diseases

Dr. Mark Pearson, VP, New Therapeutics Concept Discovery

Dr. Jan Poth, Therapeutic Area Head Immunology & Vice President Marketing, Pipeline Products

Mr. Ralph Mark, Director, External Partnerships and Financial Strategy

Dr. Juergen Reess, Therapeutic Area Head CNS

Dr. Oliver Reuss, Head of Business Model & HealthCare Innovation

Dr. Ioannis Sapountzis, Global Head Oncology, Bus. Dev. & Licensing/Prescription Medicines

Prof. Dr. Gerd Schnorrenberg, Senior Executive Advisor, R&D non-clinical

Dr. Margrit Schwarz, VP, Cardiometabolic Diseases Research

Dr. Peter Seither, Senior Manager, Scientific Collaborations

Dr. Bernd Sommer, Head of CNS Research

Dr. Georg van Husen, Therapeutic Area Head Cardiovascular

Dr. Clive Wood, Corp. SVP, Discovery Research

Dr. Johannes Zanzinger, Global Head Cardiometabolic Diseases, Bus. Dev. & Licensing/Prescription Medicines

 

IHIF Announces MOMENTUM Program Manager

August 17, 2015

Advances Regional Partnership with Kentucky Counterpart

Momentum Logo June 2014

August 17, 2015 (INDIANAPOLIS, IN AND LOUISVILLE, KY) – The Indiana Health Industry Forum (IHIF) is pleased to announce that Andrew Steen will be serving as the Program Manager, Regional Innovation Services in a joint role with the Kentucky Life Sciences Council (KLSC), IHIF’s counterpart organization.  Steen will manage the first cycle of the MOMENTUM:Team Mentorship program, the leading piece of IHIF’s newly introduced mentorship initiative.  He will also be responsible for development of a one-year work plan for a joint state initiative to leverage the region’s life science academic, entrepreneurial, and commercial resources.

Steen has spent the past 15 years working within an academic medical center, principally focused on life science commercialization efforts. He was most recently the Interim President and CEO of MetaCyte Business Lab LLC, a subsidiary of the University of Louisville Foundation, Inc. During his time at MetaCyte Andy worked with scientists and clinicians to create companies, often functioning as part of the founding entrepreneurial team. Andy has built a significant industry network which he is able to leverage on behalf of MOMENTUM participants.

“We are incredibly lucky to have someone with Andy’s extensive background and experience leading this Cycle of MOMENTUM”, said Kristin Jones President and CEO of the Indiana Health Industry Forum.  “Having him on board with the program puts our mentors and entrepreneurs ahead of the game.  We are also delighted to be able to partner with the KLSC to build out a more cohesive regional strategy to better leverage and support entrepreneurs, academia, and industry.  MOMENTUM fits well with this broader strategy and this partnership should serve as a model to include other states as we go forward”.

Dr. Kyle Keeney, President and CEO of the KLSC said, ”this initiative is all about making it easier to connect ideas, people, and resources in the most efficient and effective ways possible.  The Kentucky-Indiana relationship is strong and both states can only benefit from greater knowledge of each other’s assets.  Andy Steen is now uniquely positioned to bring that vision to fruition. We couldn’t be more pleased to be working with IHIF on building a system that supports entrepreneurs in both states”.

The first 10-week Cycle of MOMENTUM:Team Mentorship will begin in September 2015 and features mentee companies B2S Labs, Sintact Medical Systems, and Reclaim Rx.  The program is being supported by CTSI, Barnes & Thornburg, The Indiana Office of Small Business and Entrepreneurship (OSBE)/ISBDC and the Gayle and Bill Cook Center for Entrepreneurship at Ivy Tech, Bloomington.  If you would like to learn more about becoming a MOMENTUM:Mentor or program sponsor, please visit http://www.ihif.org/pages/mentorship.

###

About IHIF

The Indiana Health Industry Forum (IHIF) is a statewide trade association representing members of Indiana’s health science business community.  The diverse members of IHIF generate the collective voice of the state’s health and life science industry.  Our mission is to connect key stakeholders to: enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation.  For more information and to become a member, please visit www.ihif.org

About KLSC

The mission of the Kentucky Life Sciences Council is to provide advocacy and commercialization support that promote the life science community in Kentucky. For more information please see https://kysciencecouncil.org

About MOMENTUM

MOMENTUM:Mentor Networks is a comprehensive set of programs designed to support Indiana’s health science sector and better tie industry, our research community, and our entrepreneurs together.  The programs will encourage earlier interaction between industry and investigators, provide earlier feedback on ideas and company development, and encourage later stage entrepreneurial growth and development.  To learn more, please visit http://www.ihif.org/pages/mentorship

IHIF Announces First MOMENTUM:Team Mentorship Class

August 12, 2015

Thanks to Cycle I Sponsors: CTSI, OSBE/ISBDC, Barnes & Thornburg, and Ivy Tech

MOMENTUM:Mentor Networks is a comprehensive set of programs designed to support Indiana’s health science sector and better tie industry, our research community, and our entrepreneurs together.  The programs will encourage earlier interaction between industry and investigators, provide earlier feedback on ideas and company development, and encourage later stage entrepreneurial growth and development.

Momentum Logo June 2014

For Immediate Release

Contact: Kristin Jones, IHIF, 317-686-0994

kjones@ihif.org

 

August 13, 2015 (INDIANAPOLIS, IN)  – The Indiana Health Industry Forum (IHIF) is pleased to announce that the first class of mentee companies has been accepted into its MOMENTUM:Team Mentorship Program.  The companies participating in the first 10-week Cycle include: B2S Labs, Reclaim Rx, and Sintact Medical Systems.

The entrepreneurs will first present their companies to the MOMENTUM mentors, invited investors, steering committee, and IHIF Board of Directors at a First Pitch event scheduled for September 1.  Following the First Pitch, the companies will be matched with mentor teams and MBA student Project Managers to begin a 10-week session and conclude with a Final Pitch in December.

About the Companies:

B2S Labs (R. Aleks Davis, CEO) defines itself as a biotherapeutic enablement company, offering improved analytical methods and outcomes for companies involved in the development of biotherapeutic drugs and diagnostics. Our mission is to leverage extensive expertise in bioanalytical methods development to provide superior custom reagent products and services that are tailored to our clients’ needs, and to manage these products and services for clients throughout the drug development process.

Reclaim Rx (Eric Graban, Founder/CEO) offers protein analysis and imaging using a mass spec based covalent labeling process.  Data from our technology can provide insight into protein structure changes or binding interactions that would be difficult to obtain otherwise.

Sintact Medical Systems, Inc. (Erik Robinson, Ph.D., CEO) develops non-resorbable films that separate adjacent organs and prevent them from adhering to each other after surgery.

“On behalf of IHIF and the MOMENTUM Steering Committee, we are thrilled to announce our first class of Mentee companies for the MOMENTUM: Team Mentoring program.  B2S Labs, Reclaim Rx, and Sintact Medical Systems are an ideal group to work with and our mentors are ready and committed to help”, said Kristin Jones, President and CEO of the Indiana Health Industry Forum.  “MOMENTUM is the type of program that moves Indiana into an elite tier of life science clusters and leverages the needs and interests of our diverse industry base.  We are especially grateful to our sponsors and supporters, the Indiana Clinical and Translational Sciences Institute (CTSI), Barnes & Thornburg, The Gayle and Bill Cook Center for Entrepreneurship at Ivy Tech, and the Indiana Office of Small Business and Entrepreneurship (OSBE)/ISBDC.”

To find out more about MOMENTUM or apply to become a mentor, mentee, or MBA student project manager, please visit the MOMENTUM website at www.ihif.org/pages/mentorship

###

About IHIF

The Indiana Health Industry Forum (IHIF) is a statewide trade association representing members of Indiana’s health science business community.  The diverse members of IHIF generate the collective voice of the state’s health and life science industry.  Our mission is to connect key stakeholders to: enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation.  For more information and to become a member, please visit www.ihif.org

Indiana Health Industry Forum Receives Grant to Support MOMENTUM: Mentor Networks

July 20, 2015

Contact: Kristin Jones, IHIF

Tel:317-686-0994

kjones@ihif.org

Momentum Logo June 2014

(Indianapolis, IN – July 21, 2015) The Indiana Health Industry Forum (IHIF) is pleased to announce it has been awarded a grant from the Indiana Clinical and Translational Sciences Institute (CTSI) to support its MOMENTUM Mentor Networks program.  The MOMENTUM program was formally launched in May of 2014 and currently has over 25 accepted mentors enrolled.

MOMENTUM is intended to better tie industry, Indiana’s research community, and our entrepreneurs together.  The programs will encourage earlier interaction between industry and investigators, provide earlier feedback on ideas and company development, and encourage later stage entrepreneurial growth and development.  The program works across three functional areas and is intended to compliment the work done by existing university programs.  The areas include:

1) Connect the research and discovery interests of large industry with faculty members in the state’s research universities. Discovery Days programs will help industry become more familiar with members of Indiana’s research community and help give investigators more direct context and applications for their discoveries.

2) Provide individual investigators who would like to commercialize their discoveries with access to a customized network of industry mentors. The PRIMER program will provide guidance and feedback at the earliest stages of discovery and contemplated company formation.

3) Work with established entrepreneurial companies to enhance their business skills and build their networks.  The Team Mentorship program will work to prepare entrepreneurial companies to compete more effectively for funding.

IHIF President Kristin Jones said, “As Indiana’s health science sector has grown and developed, we have cultivated a rich resource of individuals with a variety of experiences in starting and guiding companies, raising funds, managing teams, and building business networks. To truly advance life sciences in Indiana we need a market differentiator – a program that will put us in league with other major life science clusters and allow us to tap into both our local expertise and engage large industry through more effective and efficient dialogue.  In Indiana, IHIF is uniquely positioned to be a communication bridge between large industry, the state’s business leaders, and health science entrepreneurs – making sure that the needs of each group are met through facilitated interactions and a variety of targeted programming”.

The need for a well-developed mentor program was first identified in IHIF’s Statewide Strategic Plan for Indiana’s Health Science Sector 2012-2017.  MOMENTUM specifically supports recommendations around developing statewide support infrastructure for the sector, providing tools to help familiarize investors with Indiana companies and researchers, facilitating research-based interactions between industry and universities, and providing ongoing support for CTSI’s mission and activities.

The core of the program is the team mentorship initiative, a dedicated 10-week cycle for mentee companies.  Selected businesses will be asked to present to an audience of prospective mentors in a First Pitch event.  Mentors will be asked to select companies they would be interested in mentoring.  While Mentor interest will be considered in the selection process, the program Steering Committee will organize mentor teams, working to meet the needs and interests of the mentee company.  Once matched, the teams will begin a 10 week series of weekly, 1-2 hour meetings to discuss a variety of business preparedness issues.  IHIF will provide discussion guidelines and support materials but expect teams to help mentees to think critically about these issues and how they apply to their business, not necessarily completely resolve each topic.  Additional time and discussion may be allocated to other issues as needed.  Mentee companies will also participate in a one-day training session to hone their presentation skills and will then be asked to present their new slide decks to the members of the mentor network in the Final Pitch event.  IHIF expects to organize two cycles of 3-5 mentee companies per year.

The Discovery Days Program was launched in June of 2014.  The CTSI grant was provided to support further development of the Program to connect Relevant Industry Mentors and Entrepreneur-Researchers (PRIMER).  PRIMER will be a key part of the network to encourage investigator/mentor interactions and to attract and grow the mentor resource network.

An open call for mentee company applications has been issued.  For anyone interested in learning more about team mentoring or becoming a program mentor, mentee company, or program sponsor, please visit www.ihif.org/pages/mentorship.

Funding for this program has been made through the Indiana Clinical and Translational Sciences Institute with partial support from the Indiana Economic Development Corporation Twenty-First Century Research and Technology Fund (Grant ID: A293-5-21Fund-14).

About IHIF

The diverse corporate members of the Indiana Health Industry Forum (IHIF) generate the collective voice of the state’s health and life science industry. Our mission is to connect key stakeholders to enhance members’ business networks, advocate for member interests, develop workforce skills, and provide strategic vision and leadership in the interest of growing the state’s health industry economy and reputation.  To learn more, please visit www.ihif.org

About CTSI

The Indiana Clinical and Translational Sciences Institute (CTSI) is a statewide collaboration of Indiana UniversityPurdue University and the University of Notre Dame, as well as public and private partnerships, which facilitates the translation of scientific discoveries in the lab into clinical trials and new patient treatments in Indiana and beyond.

Established in 2008, the Indiana CTSI is supported by a $55 million Clinical and Translational Science Award from the National Center for Advancing Translational Sciences (NCATS) of the National Institutions of Health, supplemented by nearly $60 million from the state, the three member universities, and public and private partnerships. The Indiana CTSI is a member of a national network of 61 CTSA-funded organizations across the United States.

Want to learn more about how the Indiana CTSI can benefit your department or unit? Schedule a visit.

Momentum Logo June 2014

Indiana Health Industry Forum (IHIF) Builds MOMENTUM

May 12, 2014

Issues Call for Local Life Science Mentors  

For Immediate Release

Press contact: Kristin Jones, IHIF

Tel: 317-524-4769 or info@ihif.org

 

INDIANAPOLIS (May 12, 2014) – The Indiana Health Industry Forum (IHIF), the state’s trade association for companies in the health science sector, has announced MOMENTUM Mentor Networks, a three-part program intended to better tie large industry, the state’s life science research community, and our health science entrepreneurs together.

With overall goals of encouraging earlier interaction between industry and university investigators, providing earlier feedback on ideas and company development, and encouraging later stage entrepreneurial growth and development, the program fills a well-known gap. “The lack of mentorship opportunities was clearly noted in the focus groups and interviews conducted for the development of our Statewide Strategic Plan for Indiana’s Health Science Sector”, said IHIF President and CEO, Kristin Jones. “We have been working for some time now to develop a comprehensive program to better connect entrepreneurs and industry members. With Team Mentoring, the first of the three programs we’ll be offering, our goal is to build a network of Indiana companies that are better prepared and qualified to meet the challenges of a more competitive funding environment by tapping into the collective expertise of a group of A-list individuals with broad experience and deep personal business networks. We believe that such a program will provide Indiana with an important competitive advantage in the life sciences”.

The Team Mentorship Program is a dedicated 10-week program cycle for mentee companies, during which they will develop a company presentation and one-page summary suitable for use in presenting to potential investors. IHIF is opening enrollment for people interested in serving as part of a team of mentors to entrepreneurial companies.

According to Rose Mary Hontz, IHIF MOMENTUM Program Manager, mentors should be motivated by several factors:

  • Be interested in new ideas.
  • Motivated to give back.
  • Looking for opportunities to network.
  • Willing to build relationships with up and coming entrepreneurs and other mentors.
  • Be eager to access the region’s most exciting opportunities

“Mentors may apply directly to IHIF or be referred to the program and will need to complete a short application form. We’ll meet individually with prospective mentors to screen the applicants and provide information about mentor responsibilities and rules of conduct”, said Hontz.  “Our Mentors will have an “A-list” reputation and selected Mentors will be recognized on the IHIF website”.

IHIF is particularly seeking mentors with expertise in several categories, including: legal, financial, regulatory affairs, past entrepreneurship, marketing, and other related business advisory roles. For more information on MOMENTUM and the Team Mentorship program, please visit http://www.ihif.org/pages/mentorship.

The program announcement was made as part of the IHIF’s 2014 Annual Meeting, celebrating the organization’s 20th anniversary. Formed in 1994, IHIF was among the first organizations dedicated to building the state’s health and life science business community. Membership currently stands at over 118 businesses and organizations and is comprised of companies ranging from large industry to entrepreneurs across several sectors including: healthcare, medical device, pharma/biotech, digital health, education, and support services.

###

About IHIF

The diverse members of the Indiana Health Industry Forum generate the collective voice of the state’s health and life science industry. The Forum connects key stakeholders to enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation. IHIF is the Indiana affiliate of the Biotechnology Industry Organization. To learn more, please visit www.ihif.org